Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tiandan Tongluo Capsule for Recovery-Phase Cerebral Infarction
ChiCTR2400081379Phase 4Recruiting
- Sponsor
- Guangdong Provincial Hospital of Traditional Chinese Medicine
- Start
- Feb 2024
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Tiandan Tongluo in brain infarction and ischemic stroke (2 arms), sponsored by Guangdong Provincial Hospital of Traditional Chinese Medicine. Primary endpoint: Change from baseline in NIHSS score at 12 weeks of medication. Started Feb 2024; status: recruiting.
02
Drugs
Tiandan Tongluo
03
Conditions
brain infarctionischemic stroke
Beyond the preview
Go deeper on ChiCTR2400081379.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400081379.